Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,513,362
New position
Shares Held
71,019
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#187
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Havemeyer Place LP holds $27,177,295 across 19 Biotechnology names. ROIV ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,415 | $2,834,197 | |
| 2 | ROIV |
Roivant Sciences Ltd.
This page
|
71,019 | $2,513,362 | |
| 3 | QURE |
uniQure N.V.
|
50,812 | $2,340,400 | |
| 4 | INSM |
INSMED Inc
|
19,121 | $2,038,681 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
33,490 | $1,916,297 | |
| 6 | BNTX |
BioNTech SE
|
20,283 | $1,887,333 | |
| 7 | ARGX |
Argenx SE
|
1,948 | $1,807,295 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,248 | $1,529,322 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,513,362 | 71,019 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||